Justin Hanka: LSD Microdosing Clinical Trials

<p>Justin Hanka is the Co-Founder and Chief Executive Director of MindBio Therapeutics, world leaders in microdosing of psychedelics,</p><br><p>Justin joins the Mycopreneur Podcast from his home in Melbourne, Australia to discuss the rigorous scientific inquiry and data collection that MindBio therapeutics is conducting in Phase 2 clinical trials assessing the medical efficacy of microdosing LSD to treat Major Depressive Disorder.&nbsp;</p><br><p>We discuss the process of clinical trials, the data collected from MindBio Therapeutics Phase 1 clinical trials, what regulators need in order to approve psychedelics as a treatment model for Major Depressive Disorder, and the toppling data that is eradicating lingering stigma against psychedelic medicines in the medical establishment and society at large.</p><br><p>Please consider rating, reviewing, and sharing the podcast wherever you're listening.&nbsp;</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>